Search

everythinglearnresearchcommunity

for

Search:↓

Oral mucosa heals with minimal scarring, offering insights for scarless wound healing.

The subcutaneous fascia is key to fast wound healing and could improve treatments for chronic wounds and scarring.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Noninvasive scalp imaging techniques can improve patient care by reducing the need for biopsies.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

EGFR helps protect hair follicles from damage and scarring.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

IgG4-related disease can cause scalp hair loss that looks like acne keloidalis nuchae.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

CCCA may be caused by both hair traction and an immune response.